Courtagen Life Sciences Announces Partnership With Seizure Tracker To Better Understand Relationships Between Genetics, Seizure Activity And Anti-epileptic Treatments
6/19/2014 11:32:59 AM
WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, an innovative molecular information company offering genetic testing for epilepsy and seizure disorders, announced today an agreement with Seizure Tracker. Founded by parents of a son who suffered from daily seizures, the online epilepsy diary found at SeizureTracker.com allows patients to create personalized reports of logged seizure activity and treatment history that can be easily shared with their medical team.
Help employers find you! Check out all the jobs and post your resume.
comments powered by